Unfolding Severe and Enduring Eating Disorders (U-SEED)

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The main aim of this study is to identify biological and psychological characteristics as risk factors in individuals with severe and enduring eating disorders (SEED). Specifically, the investigators aim to: 1. in a cohort of well-diagnosed eating disorder patients from 2005 followed up in National health registers, explore risk factors at baseline (recorded 2005-2007) for development of later SEED (the registry based cohort). 2. replicate the findings in a new sample of 50 adults with ongoing SEED. Participants will be assessed diagnostically and physically, and asked to fill out questionnaires and leave blood samples (the ongoing SEED sample compared with the register based cohort). 3. in a sample of 50 adults with SEED, explore demographic, biological, clinical, and psychological factors and examine the relation between these factors and symptom severity and functional impairment (the ongoing SEED sample). 4. explore participants perspectives on their symptoms and received care (the ongoing SEED sample).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

⁃ For aim 1 (register based cohort):

⁃ Incl. criteria:

⁃ Attended care for eating disorders at Uppsala University Hospital between 2005 and 2007 and accepted to be included in a local quality register.

⁃ Excl. criteria: None

⁃ For aim 2 (ongoing SEED sample and register based cohort)

⁃ Incl. criteria:

• For ongoing SEED sample: Minimum age of 18, impairing eating disorder symptoms for at least seven years, and having at least one evidence-based treatment without remission or resulting in relapse.

• For register based cohort, see above.

⁃ Excl. criteria:

• For ongoing SEED sample: Eating disorders symptoms in need of emergency care, high risk for suicide, and an inability to respond to the questionnaires due to lack of knowledge in Swedish.

⁃ For aim 3 and 4 (the ongoing SEED sample). See above.

Locations
Other Locations
Sweden
Uppsala University Hospital
RECRUITING
Uppsala
Contact Information
Primary
Martina Isaksson
martina.isaksson@uu.se
0706954108
Backup
Mia Ramklint
mia.ramklint@uu.se
0730949181
Time Frame
Start Date: 2024-06-01
Estimated Completion Date: 2026-04
Participants
Target number of participants: 50
Related Therapeutic Areas
Sponsors
Collaborators: Forte, The Söderström König Foundation
Leads: Uppsala University Hospital

This content was sourced from clinicaltrials.gov